Nikhil Ananth

Investment Stage

Focus Areas

About Investor

Nikhil Ananth is a Principal at F-Prime Capital, based in Cambridge, Massachusetts, United States, specializing in healthcare and life sciences venture capital investments. His investment focus spans Medical Devices, Health IT, Health & Hospital Services, BioTech, Therapeutics, Research Tools, and Life Science Software & Services. His investment activity primarily covers the Seed and Series A stages, making him particularly relevant to healthcare and biotechnology companies developing innovative medical technologies, validating clinical applications, and preparing for commercialization. According to his Signal investor profile, Nikhil's investment range is approximately $100,000 to $10 million, with a preferred ticket of around $5 million. Since joining F-Prime in 2019, he has supported investments in companies including Adela, Countable Labs, Ensoma, Galatea Bio, Invetx, Ivenix, Metsera, and Rallybio. He also collaborates with Eight Roads Ventures on F-Prime's healthcare investments in India, providing exposure to international healthcare investment opportunities. His profile does not explicitly establish whether he generally acts as a lead investor. Through his venture capital experience and previous private equity work at Audax Group, Nikhil is positioned to support founders with investment evaluation, fundraising, healthcare commercialization, strategic planning, business development, and scaling life sciences companies